Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy.

Publication date: Available online 28 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): M. Jonakowski, I. Kuprys-Lipinska, P. Lacwik, M. Stasiolek, M. Matysiak
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research